<DOC>
	<DOC>NCT02795780</DOC>
	<brief_summary>This study will evaluate longitudinal change of tau deposition as measured by 18F-AV-1451 uptake over time.</brief_summary>
	<brief_title>Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Confirmatory cohort subjects who completed the 18FAV1451A05 (NCT02016560) study Current clinically significant cardiovascular disease, ECG abnormalities, risk factors for Torsades de Pointes (TdP), or are taking drugs know to cause QT prolongation Current clinically significant infectious disease, endocrine or metabolic disease, pulmonary, renal or hepatic impairment, or cancer Females of childbearing potential who are not surgically sterile, not refraining from sexual activity or not using reliable methods of contraception Have had a nonstudy related radiopharmaceutical imaging or treatment procedure within 7 days prior to the study imaging session Have received or participated in a trial with investigational medications in the past 30 days</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>